Full Text of HB4987 102nd General Assembly
HB4987 102ND GENERAL ASSEMBLY |
| | 102ND GENERAL ASSEMBLY
State of Illinois
2021 and 2022 HB4987 Introduced 1/27/2022, by Rep. Bob Morgan SYNOPSIS AS INTRODUCED: |
| |
Amends the Cannabis Regulation and Tax Act. Provides that a cannabis business establishment licensed by the Department of Agriculture for cultivating, growing, processing, manufacturing, or infusing cannabis or a cannabis-infused product pursuant to the Cannabis Regulation and Tax Act or the Compassionate Use of Medicinal Cannabis Program Act may use industrial hemp as an ingredient in cannabis or a cannabis-infused product that is offered for sale at a dispensary. Provides that hemp flower may not be sold to a dispensary. Provides that industrial hemp may be procured from a licensed third-party grower or processor from within the State of Illinois or from any other state with a regulated industrial hemp program. Requires all hemp and hemp derivatives obtained by a cannabis business establishment to be obtained from a licensed or registered hemp grower or processor. Provides that a cultivation center that intends to use hemp or a hemp derivative must apply for, and be issued, a Hemp Processor License by the Department. Requires a representative sample of all final products containing industrial hemp or hemp derivatives to undergo specified testing. Contains other provisions. Effective immediately.
|
| |
| | A BILL FOR |
|
| | | HB4987 | | LRB102 24141 CPF 35353 b |
|
| 1 | | AN ACT concerning regulation.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 5. The Cannabis Regulation and Tax Act is amended | 5 | | by adding Section 55-100 as follows: | 6 | | (410 ILCS 705/55-100 new) | 7 | | Sec. 55-100. Hemp in cannabis-infused products. | 8 | | (a) In this Section: | 9 | | "Hemp" or "industrial hemp" has the same meaning as | 10 | | provided in Section 5 of the Industrial Hemp Act. | 11 | | (b) A cannabis business establishment licensed by the | 12 | | Department for cultivating, growing, processing, | 13 | | manufacturing, or infusing cannabis or a cannabis-infused | 14 | | product pursuant to this Act or the Compassionate Use of | 15 | | Medicinal Cannabis Program Act may use industrial hemp as an | 16 | | ingredient in cannabis or a cannabis-infused product that is | 17 | | offered for sale at a dispensary. However, hemp flower may not | 18 | | be sold to a dispensary. | 19 | | (c) Hemp obtained under subsection (b) must be used in | 20 | | extracted form and only in a cannabis-infused product. | 21 | | (d) Industrial hemp may be procured from a licensed | 22 | | third-party grower or processor from within the State of | 23 | | Illinois or from any other state with a regulated industrial |
| | | HB4987 | - 2 - | LRB102 24141 CPF 35353 b |
|
| 1 | | hemp program. | 2 | | (e) All hemp and hemp derivatives obtained by a cannabis | 3 | | business establishment must be obtained from a licensed or | 4 | | registered hemp grower or processor, regardless of the | 5 | | grower's or processor's home state. A cannabis business | 6 | | establishment that obtains hemp or a hemp derivative must | 7 | | provide a copy of the hemp grower's or processor's license | 8 | | issued by Illinois or another state upon demand of the | 9 | | Department or the Illinois State Police. | 10 | | (f) A cultivation center that intends to use hemp or a hemp | 11 | | derivative must apply for, and be issued, a Hemp Processor | 12 | | License by the Department. | 13 | | (g) Industrial hemp flower and biomass may be purchased | 14 | | and extracted by a cultivation center. | 15 | | (h) A cultivation center may procure or process industrial | 16 | | hemp in the form of distillate or isolate. All processed hemp | 17 | | derivatives must be accompanied by a certificate of analysis | 18 | | showing potency levels for delta-9 tetrahydrocannabinol (THC), | 19 | | THCa, CBD, and CBDa. | 20 | | (i) The delta-9 tetrahydrocannabinol (THC) contained in | 21 | | hemp or a hemp derivative procured or processed under | 22 | | subsection (h) may not be concentrated above the allowable | 23 | | 0.3% threshold. | 24 | | (j) Hemp or hemp derivatives may not be used to | 25 | | concentrate or to synthesize delta-9 tetrahydrocannabinol | 26 | | (THC), unless the concentration or synthesis of the hemp or |
| | | HB4987 | - 3 - | LRB102 24141 CPF 35353 b |
|
| 1 | | hemp derivative is performed at a cultivation center, craft | 2 | | grower, or infuser. | 3 | | (k) A representative sample of all final products | 4 | | containing industrial hemp or hemp derivatives must undergo | 5 | | testing pursuant to the Compassionate Use of Medical Cannabis | 6 | | Act, the Cannabis Regulation and Tax Act, and any applicable | 7 | | administrative rules.
| 8 | | Section 99. Effective date. This Act takes effect upon | 9 | | becoming law.
|
|